You are here: Industry Insights > COVID-19

News List

Johnson & Johnson Announces Lead Vaccine Candidate for COVID-19, Partners with HHS americanpharmaceuticalreview
April 03, 2020
Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020.
APEIRON Biologics Initiates Phase II COVID-19 Trial contractpharma
April 03, 2020
APN01 has potential to block infection of cells by COVID-19 virus and reduce lung injury.
Amgen, Adaptive Biotech Enter COVID-19 Antibody Alliance contractpharma
April 03, 2020
Aims to accelerate the development of a potential antibody against COVID-19 as fast as possible.
Ampio Pharma to Study Ampion in COVID-19 Induced ARDS contractpharma
April 03, 2020
Englewood pharmaceutical company looking to treat COVID-19 patients with anti-inflammatory drug.
Israeli scientists begin animal testing of Covid-19 vaccine prototype pharmaceutical-technology
April 03, 2020
The Israel Institute for Biological Research (IIBR) has made ‘significant’ progress in creating a Covid-19 vaccine prototype and preparations are underway for animal testing, said Prime Minister Benjamin Netanyahu.
ImmunityBio and Microsoft create 3D model to support Covid-19 research pharmaceutical-technology
April 03, 2020
Immunotherapy company ImmunityBio has partnered with Microsoft to leverage the latter’s Azure platform to create a 3D model of Covid-19’s spike protein.
EMA advises malaria drugs use for trials only; FDA records shortage pharmaceutical-technology
April 03, 2020
The European Medicines Agency (EMA) has urged that two malaria drugs, chloroquine and hydroxychloroquine, being tested as potential Covid-19 treatment, must only be used for clinical trials or national emergency use programmes.
Gilead initiates two studies of remdesivir for Covid-19 in UK pharmaceutical-technology
April 03, 2020
Gilead Sciences has launched two Phase III clinical trials of its investigational antiviral drug remdesivir in the UK to treat Covid-19 patients.
Citius licences Novellus’ stem cell therapy for Covid-19-related ARDS pharmaceutical-technology
April 03, 2020
Citius Pharmaceuticals has entered an exclusive six-month option agreement to licence a stem cell therapy from Novellus to treat acute respiratory distress syndrome (ARDS) related to Covid-19 infection.
Ethris, Neurimmune work on inhalable COVID-19 therapy pharmatimes
April 02, 2020
Joining the fight against COVID-19, Ethris GmbH and Neurimmune AG have announced an exclusive partnership to develop an mRNA-based anti-SARS-CoV-2 antibody therapeutic as an inhalable COVID-19 treatment.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page